Three Fool.com contributors have ideas on up-and-coming growth stocks to buy right now. Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Sarepta Therapeutics (NASDAQ: SRPT), and Travere Therapeutics (NASDAQ: TVTX). Keith Speights (Axsome Therapeutics): Some small drugmakers have all of their eggs in one basket with only one pipeline candidate.
Sarepta Therapeutics (SRPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Sarepta Therapeutics' (SRPT) shares plunged almost 20% as the FDA decides to hold an advisory meeting for the BLA of its lead gene therapy candidate SRP-9001.